Sacral chordoma: clinical experience of a series of 11 patients over 18 years
- 96 Downloads
Sacral chordoma are rare low-to-intermediate grade malignant tumours that occur most commonly within the sacrum. Sacrectomy with wide resection margins seems to offer the best long-term prognosis. This study aims to review the management of sacral chordomas including the duration of symptoms, features, treatment, complications and local recurrence rate following surgery at a tertiary centre. We retrospectively reviewed 11 patients treated at our institution between years 1999 and 2015. Patient data included age, sex, history, radiographs, surgical details, onset of recurrence, subsequent treatment, disease-free survival and overall survival were analyzed. Nine patients underwent surgical management with 1 through a sacral approach and eight patients through a combined abdominosacral approach. Despite wide resection in our series, sacral chordoma poses a major problem with approximately 60% of patients having local recurrence in their follow-up.
KeywordsSacral chordoma Management Recurrence
Compliance with ethical standards
Conflict of interest
All authors declare that there is no conflict of interest for this study.
- 1.Dahlin DC, Unni KK (1986) Bone tumors: general aspects and data on 8,547 cases, 4th edn, chap 26. Charles C. Thomas Publisher LTD, Chordoma, US, pp 379–393Google Scholar
- 3.Bergh P, Kindblom LG, Gunterberg B, Remotti F, Rdy W, Meis-Kindblon JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88: 2122–2134. https://doi.org/10.1002/(SICI)1097-0142(20000501)88:9%3c2122::AID-CNCR19%3e3.0.CO;2-1
- 9.Hoskin PJ, Neal AJ (2003) Clinical oncology 3rd edn, basic principles + practice: CNS tumours. Arnold, Hodder Headline Group, London, p 161Google Scholar
- 20.Koh PK, Tan BK, Hong SW, Tan MH, Tay AG, Song C, Tan KC (2004) The gluteus maximus muscle flap for reconstruction of sacral chordoma defects. Ann Plast Surg 53(1):44–49. https://doi.org/10.1097/01.sap.0000106423.87203.a3 CrossRefPubMedGoogle Scholar
- 26.Horbinski C, Oakley GJ, Cieply K, Mantha GS, Nikoforova MN, Dacic S, Seethala RR (2010) The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas. Arch Pathol Lab Med 134(8):1170–1176. https://doi.org/10.1043/2009-0380-OA.1 CrossRefPubMedPubMedCentralGoogle Scholar